Skip to main content
William Bishai, MD, Infectious Disease, Baltimore, MD, Johns Hopkins Hospital

WilliamRamsesBishaiMD

Infectious Disease Baltimore, MD

Professor of Medicine, Professor of Molecular Biology and Genetics, Joint of Pathology, Johns Hopkins University School of Medicine

Are you Dr. Bishai?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 49 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. William Bishai, MD is an infectious disease specialist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is affiliated with Johns Hopkins Hospital and is a Professor of Medicine at Joint of Pathology.

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1989 - 1991
  • Harvard Medical School
    Harvard Medical SchoolClass of 1989

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1991 - 2024

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2002
  • Investigator Howard Hughes Medical Institute

Publications & Presentations

PubMed

Press Mentions

  • Omicron Linked to Rise in Croup in Babies; TB Vaccine Improves Immune Response to Coronavirus
    Omicron Linked to Rise in Croup in Babies; TB Vaccine Improves Immune Response to CoronavirusMarch 16th, 2022
  • Omicron Linked to Increased Croup in Babies; Tuberculosis Vaccine Improves Immune Response to Coronavirus
    Omicron Linked to Increased Croup in Babies; Tuberculosis Vaccine Improves Immune Response to CoronavirusMarch 16th, 2022
  • COVID SCIENCE-Omicron Linked to Rise in Croup in Babies; TB Vaccine Improves Immune Response to Coronavirus
    COVID SCIENCE-Omicron Linked to Rise in Croup in Babies; TB Vaccine Improves Immune Response to CoronavirusMarch 16th, 2022
  • Join now to see all

Grant Support

  • Biomarkers And Signaling In TuberculosisNational Institute Of Allergy And Infectious Diseases2011
  • Screen For Synthetic Lethality In Mycobacterium TuberculosisNational Institute Of Mental Health2010–2011
  • M.Tb Survival Regulatory GenesNational Institute Of Allergy And Infectious Diseases2010–2011
  • Gene Regulation And Virulence In TBNational Institute Of Allergy And Infectious Diseases2010–2011
  • PK/PD Evaluation Resistance Development In Caseating GranulomaNational Institute Of Allergy And Infectious Diseases2008–2011
  • Gene Regulation And Virulence In TB And MACNational Institute Of Allergy And Infectious Diseases1999–2010
  • Screen For Synthetic Lethality In Mycobacterium TuberculosisNational Institute Of Mental Health2008
  • Mycobacterium Tuberculosis Survival Regulatory GenesNational Institute Of Allergy And Infectious Diseases2007–2008
  • Toolbox For Tuberculosis Drug DevelopmentNational Institute Of Allergy And Infectious Diseases2003–2007
  • M. TB. Survival Regulatory GenesNational Institute Of Allergy And Infectious Diseases2004–2006
  • Multidisciplinary Training In TuberculosisNational Institute Of Allergy And Infectious Diseases2001–2005
  • Cell Division Control And Virulence In MycobacteriaNational Institute Of Allergy And Infectious Diseases2001–2005
  • Latency And Reactivation TuberculosisNational Heart, Lung, And Blood Institute2002
  • Rational Drug Discovery For MAC And M TBNational Institute Of Allergy And Infectious Diseases1998–2002
  • M TB Survival Regulatory GenesNational Institute Of Allergy And Infectious Diseases1997–2001
  • Search For Genetic Regulators Of Latency In M TBNational Institute Of Allergy And Infectious Diseases1994–1998

Hospital Affiliations